Spots Global Cancer Trial Database for Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma
Official Title: Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma
Study ID: NCT02245997
Conditions
Study Description
Brief Summary: The purpose of this study is to give 12T a smaller dose of radiation in order to decrease these late side effects.
Detailed Description:
Keywords
Eligibility
Minimum Age: 12 Months
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact Details
Name: Suzanne Wolden, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
